Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The PIK3CA E545K mutation is an oncogenic point mutation in the PIK3CA gene, resulting in constitutive activation of PI3K signaling, promoting uncontrolled cell growth and survival. It is found in various cancers and can influence response to PI3K inhibitors.
Inhibition of PI3K signaling
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PIK3CA E545K Mutant (PIK3CA E545K).